PMV — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Vianovatxvianovatx.comAug 2021
Via Nova develops antiviral therapies targeting acute and subacute viral infections, including respiratory, gastrointestinal, and neurological infections.
BiotechDigital HealthMedical DevicesOakland, US
Donald Ganem(Executive Officer, Director)Benjamine Liu(Director)Ilan Zipkin(Director)
BoardJoseph Jimenez(Director)in
Co-investorsAditum Bio
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.